Skip to main content
Watch Insiders

Corporate insider profile

Krishnaswamy Yeleswaram Insider Trades

Latest reported as Chief Development Officer of Rapport Therapeutics, Inc. (RAPP).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,056,407.36
Latest transaction
Aug 25, 2026

Affiliated corporations

Reported company relationships

RAPPLatest reported

Rapport Therapeutics, Inc.

Chief Development Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 25, 2026Rapport Therapeutics, Inc. (RAPP)Chief Development OfficerSale50,160$50.47$2,531,580
Aug 19, 2026Rapport Therapeutics, Inc. (RAPP)Chief Development OfficerSale404$49.90$20,160
Apr 17, 2026Rapport Therapeutics, Inc. (RAPP)Chief Development OfficerSale20,225$39.99$808,844
Apr 14, 2026Rapport Therapeutics, Inc. (RAPP)Chief Development OfficerSale19,865$35.03$695,823